Arthur M. Cohen & Associates’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-4,825
| Closed | -$382K | – | 131 |
|
|
2025
Q2 | $382K | Buy |
4,825
+1,180
| +32% | +$93.8K | 0.07% | 97 |
|
|
2025
Q1 | $327K | Buy |
3,645
+200
| +6% | +$18.7K | 0.06% | 101 |
|
|
2024
Q4 | $343K | Hold |
3,445
| – | – | 0.06% | 107 |
|
|
2024
Q3 | $395K | Buy |
3,445
+120
| +4% | +$14.3K | 0.07% | 97 |
|
|
2024
Q2 | $412K | Buy |
3,325
+600
| +22% | +$77.3K | 0.08% | 92 |
|
|
2024
Q1 | $360K | Buy |
2,725
+89
| +3% | +$11K | 0.08% | 99 |
|
|
2023
Q4 | $287K | Sell |
2,636
-1,409
| -35% | -$146K | 0.07% | 107 |
|
|
2023
Q3 | $416K | Hold |
4,045
| – | – | 0.11% | 87 |
|
|
2023
Q2 | $467K | Buy |
4,045
+700
| +21% | +$79.5K | 0.12% | 83 |
|
|
2023
Q1 | $356K | Hold |
3,345
| – | – | 0.1% | 93 |
|
|
2022
Q4 | $371K | Buy |
3,345
+500
| +18% | +$51.1K | 0.1% | 96 |
|
|
2022
Q3 | $245K | Hold |
2,845
| – | – | 0.07% | 111 |
|
|
2022
Q2 | $259K | Sell |
2,845
-140
| -5% | -$12.4K | 0.06% | 112 |
|
|
2022
Q1 | $245K | Sell |
2,985
-6,298
| -68% | -$497K | 0.05% | 120 |
|
|
2021
Q4 | $711K | Sell |
9,283
-1,990
| -18% | -$159K | 0.13% | 84 |
|
|
2021
Q3 | $847K | Sell |
11,273
-5,130
| -31% | -$390K | 0.17% | 72 |
|
|
2021
Q2 | $1.28M | Sell |
16,403
-13,594
| -45% | -$1.01M | 0.25% | 59 |
|
|
2021
Q1 | $2.98M | Sell |
29,997
-21,101
| -41% | -$1.56M | 0.69% | 32 |
|
|
2020
Q4 | $3.99M | Sell |
51,098
-420
| -0.8% | -$32.1K | 0.94% | 21 |
|
|
2020
Q3 | $4.08M | Buy |
51,518
+189
| +0.4% | +$14.8K | 1.06% | 19 |
|
|
2020
Q2 | $3.75M | Buy |
51,329
+2,164
| +4% | +$163K | 1.13% | 19 |
|
|
2020
Q1 | $3.47M | Sell |
49,165
-1,383
| -3% | -$109K | 1.38% | 18 |
|
|
2019
Q4 | $4.39M | Sell |
50,548
-1,646
| -3% | -$135K | 1.35% | 17 |
|
|
2019
Q3 | $4.19K | Buy |
52,194
+1,760
| +3% | +$141K | 1.18% | 18 |
|
|
2019
Q2 | $4.04M | Buy |
50,434
+3,836
| +8% | +$294K | 1.38% | 18 |
|
|
2019
Q1 | $3.71M | Buy |
46,598
+3,543
| +8% | +$265K | 1.33% | 17 |
|
|
2018
Q4 | $3.14K | Sell |
43,055
-1,383
| -3% | -$97.6K | 1% | 19 |
|
|
2018
Q3 | $3.01K | Hold |
44,438
| – | – | 0.92% | 19 |
|
|
2018
Q2 | $2.57M | Sell |
44,438
-105
| -0.2% | -$5.92K | 0.97% | 21 |
|
|
2018
Q1 | $2.28M | Buy |
44,543
+1,488
| +3% | +$80.4K | 0.86% | 26 |
|
|
2017
Q4 | $3.14K | Buy |
+43,055
| New | +$2.39M | 0.86% | 18 |
|
|
2017
Q2 | $2.92M | Buy |
49,147
+2,000
| +4% | +$122K | 1.15% | 25 |
|
|
2017
Q1 | $2.86M | Sell |
47,147
-954
| -2% | -$57.9K | 1.28% | 25 |
|
|
2016
Q4 | $2.7M | Buy |
+48,101
| New | +$2.82M | 1.43% | 21 |
|
|
2014
Q3 | $3.08M | Buy |
+50,443
| New | +$2.83M | 1.43% | 22 |
|
Other funds holding MRK
Arthur M. Cohen & Associates's MRK Position: Q3 2025 in Review
Arthur M. Cohen & Associates sold out of Merck (MRK) in Q3 2025, closing a stake of 4,825 shares — an estimated $382K sold.
Arthur M. Cohen & Associates first reported a position in MRK in Q3 2014 and held it in 35 quarters. The position peaked at $4.39M in Q4 2019. 3,310 funds tracked by Wall St. Rank hold MRK as of Q3 2025.
- Arthur M. Cohen & Associates reported no remaining Merck position as of Q3 2025 after selling out during the quarter.
- Arthur M. Cohen & Associates sold 4,825 Merck shares in Q3 2025, an estimated $382K.
- Arthur M. Cohen & Associates first reported a position in Merck in Q3 2014 and held it in 35 quarters.
- Arthur M. Cohen & Associates's Merck position peaked at $4.39M in Q4 2019.
- 3,310 funds tracked by Wall St. Rank held Merck as of Q3 2025.
Based on Arthur M. Cohen & Associates's 13F filing for Q3 2025, filed 14 Oct 2025.